HOSPIRA, INC. v. Gland Pharma Ltd.
2:10-cv-14514
Overview
Parties
Mediator
Richard D. Grauer NPE (Individual / Inventor)
Represented By
1 Attorneys Listed1006 Stratford Lane
1006 Stratford Lane, Bloomfield Hills, MI 48304
Richard D. Harris NPE (Individual / Inventor)
Represented By
0 Attorneys ListedDefendant
Sun Pharmaceutical Industries, Inc. Operating Company
Represented By
2 Attorneys ListedBodman PLC
Bodman PLC, 6th Floor at Ford Field
Caraco Pharmaceutical Laboratories, Ltd. Operating Company
Represented By
2 Attorneys ListedBodman PLC
Bodman PLC, 6th Floor at Ford Field
Plaintiff
Court & Judges
Court
District Court, E.D. Michigan (mied)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → |
Baxter Healthcare Corporation v. Hospira, Inc.
Hospira Inc. v. Eurohealth International Sarl
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6716867
Use of dexmedetomidine for ICU sedation
|
Filed: 1999-03-31
Issued: 2004-04-06
|
Expired (Term Ended)
Expires: 2019-03-31
|
|
|
US4910214
Optical isomer of an imidazole derivative medetomidine as an alpha-2-receptor agonist
|
Filed: 1988-07-15
Issued: 1990-03-20
|
Expired (Term Ended)
+1826d PTA
Expires: 2013-07-15
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
20
Dispositive
8
Granted
1
Denied
3
Pending / Review
14
Motions by Category
Key Dispositive Motions & Rulings